2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Colorectal Neoplasms
7
Colonic Neoplasms
6
Colonic Polyps
4
Inflammatory Bowel Diseases
3
Surgical Wound Infection
2
Rectal Neoplasms
2
Neoplasms
2
Melanoma
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Sarcoma
1
Polyps
1
Ovarian Neoplasms
1
Opioid-Induced Constipation
1
Lymphoma, Non-Hodgkin
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Intestinal Neoplasms
1
Gastrointestinal Hemorrhage
1
Diverticulitis
1
Colonic Diseases
1
Cancer Pain
1
Adenoma
1
Interventions
naloxegol
8
tegaserod
3
naldemedine
3
prucalopride
1
methylnaltrexone
1
linaclotide
1
alvimopan
1
Polyethylene Glycols
1
Oxycodone
1
Magnesium Hydroxide
1
Lubiprostone
1
Electrolytes
1
Electroacupuncture
1
Dosage Forms
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Opioid-Induced Constipation
×
Polyethylene Glycols
×
Clear all
NCT05216328
2024-11-22
OMAMA
Amsterdam UMC, location VUmc
Phase 4
Recruiting
330 enrolled